99 related articles for article (PubMed ID: 24768146)
1. Evaluation of metabolism, plasma protein binding and other biological parameters after administration of (-)-[(18)F]Flubatine in humans.
Patt M; Becker GA; Grossmann U; Habermann B; Schildan A; Wilke S; Deuther-Conrad W; Graef S; Fischer S; Smits R; Hoepping A; Wagenknecht G; Steinbach J; Gertz HJ; Hesse S; Schönknecht P; Brust P; Sabri O
Nucl Med Biol; 2014 Jul; 41(6):489-94. PubMed ID: 24768146
[TBL] [Abstract][Full Text] [Related]
2. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
Sabri O; Becker GA; Meyer PM; Hesse S; Wilke S; Graef S; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Habermann B; Neuhaus P; Fischer S; Tiepolt S; Deuther-Conrad W; Barthel H; Schönknecht P; Brust P
Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057
[TBL] [Abstract][Full Text] [Related]
3. (+)-[
Tiepolt S; Becker GA; Wilke S; Cecchin D; Rullmann M; Meyer PM; Barthel H; Hesse S; Patt M; Luthardt J; Wagenknecht G; Sattler B; Deuther-Conrad W; Ludwig FA; Fischer S; Gertz HJ; Smits R; Hoepping A; Steinbach J; Brust P; Sabri O
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):731-746. PubMed ID: 32935187
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Metabolism of (+)-[
Ludwig FA; Fischer S; Smits R; Deuther-Conrad W; Hoepping A; Tiepolt S; Patt M; Sabri O; Brust P
Molecules; 2018 Feb; 23(2):. PubMed ID: 29461507
[TBL] [Abstract][Full Text] [Related]
5. Imaging of cerebral α4β2* nicotinic acetylcholine receptors with (-)-[(18)F]Flubatine PET: Implementation of bolus plus constant infusion and sensitivity to acetylcholine in human brain.
Hillmer AT; Esterlis I; Gallezot JD; Bois F; Zheng MQ; Nabulsi N; Lin SF; Papke RL; Huang Y; Sabri O; Carson RE; Cosgrove KP
Neuroimage; 2016 Nov; 141():71-80. PubMed ID: 27426839
[TBL] [Abstract][Full Text] [Related]
6. LC-MS Supported Studies on the in Vitro Metabolism of both Enantiomers of Flubatine and the in Vivo Metabolism of (+)-[(18)F]Flubatine-A Positron Emission Tomography Radioligand for Imaging α4β2 Nicotinic Acetylcholine Receptors.
Ludwig FA; Smits R; Fischer S; Donat CK; Hoepping A; Brust P; Steinbach J
Molecules; 2016 Sep; 21(9):. PubMed ID: 27617996
[TBL] [Abstract][Full Text] [Related]
7. Internal dose assessment of (-)-18F-flubatine, comparing animal model datasets of mice and piglets with first-in-human results.
Sattler B; Kranz M; Starke A; Wilke S; Donat CK; Deuther-Conrad W; Patt M; Schildan A; Patt J; Smits R; Hoepping A; Schoenknecht P; Steinbach J; Brust P; Sabri O
J Nucl Med; 2014 Nov; 55(11):1885-92. PubMed ID: 25286922
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of (-)-[
Bhatt S; Hillmer AT; Nabulsi N; Matuskey D; Lim K; Lin SF; Esterlis I; Carson RE; Huang Y; Cosgrove KP
Synapse; 2018 Mar; 72(3):. PubMed ID: 29105121
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of both enantiomers of [(18)F]flubatine, promising radiotracers with fast kinetics for the imaging of α4β2-nicotinic acetylcholine receptors.
Smits R; Fischer S; Hiller A; Deuther-Conrad W; Wenzel B; Patt M; Cumming P; Steinbach J; Sabri O; Brust P; Hoepping A
Bioorg Med Chem; 2014 Jan; 22(2):804-12. PubMed ID: 24369841
[TBL] [Abstract][Full Text] [Related]
10. (-)-[(18) F]Flubatine: evaluation in rhesus monkeys and a report of the first fully automated radiosynthesis validated for clinical use.
Hockley BG; Stewart MN; Sherman P; Quesada C; Kilbourn MR; Albin RL; Scott PJ
J Labelled Comp Radiopharm; 2013 Oct; 56(12):595-9. PubMed ID: 24285235
[TBL] [Abstract][Full Text] [Related]
11. Radiation dosimetry of the α
Kranz M; Sattler B; Tiepolt S; Wilke S; Deuther-Conrad W; Donat CK; Fischer S; Patt M; Schildan A; Patt J; Smits R; Hoepping A; Steinbach J; Sabri O; Brust P
EJNMMI Phys; 2016 Dec; 3(1):25. PubMed ID: 27770429
[TBL] [Abstract][Full Text] [Related]
12. Radiosynthesis of racemic and enantiomerically pure (-)-[18F]flubatine--a promising PET radiotracer for neuroimaging of α4β2 nicotinic acetylcholine receptors.
Fischer S; Hiller A; Smits R; Hoepping A; Funke U; Wenzel B; Cumming P; Sabri O; Steinbach J; Brust P
Appl Radiat Isot; 2013 Apr; 74():128-36. PubMed ID: 23416407
[TBL] [Abstract][Full Text] [Related]
13. [(18)F]Fallypride: metabolism studies and quantification of the radiotracer and its radiometabolites in plasma using a simple and rapid solid-phase extraction method.
Peyronneau MA; Saba W; Goutal S; Kuhnast B; Dollé F; Bottlaender M; Valette H
Nucl Med Biol; 2013 Oct; 40(7):887-95. PubMed ID: 23891202
[TBL] [Abstract][Full Text] [Related]
14. Measurement of the alpha4beta2* nicotinic acetylcholine receptor ligand 2-[(18)F]Fluoro-A-85380 and its metabolites in human blood during PET investigation: a methodological study.
Sorger D; Becker GA; Patt M; Schildan A; Grossmann U; Schliebs R; Seese A; Kendziorra K; Kluge M; Brust P; Mukhin AG; Sabri O
Nucl Med Biol; 2007 Apr; 34(3):331-42. PubMed ID: 17383583
[TBL] [Abstract][Full Text] [Related]
15. Interspecies differences in plasma protein binding of MS-275, a novel histone deacetylase inhibitor.
Acharya MR; Sparreboom A; Sausville EA; Conley BA; Doroshow JH; Venitz J; Figg WD
Cancer Chemother Pharmacol; 2006 Feb; 57(3):275-81. PubMed ID: 16028097
[TBL] [Abstract][Full Text] [Related]
16. Fully automated radiosynthesis of both enantiomers of [18F]Flubatine under GMP conditions for human application.
Patt M; Schildan A; Habermann B; Fischer S; Hiller A; Deuther-Conrad W; Wilke S; Smits R; Hoepping A; Wagenknecht G; Steinbach J; Brust P; Sabri O
Appl Radiat Isot; 2013 Oct; 80():7-11. PubMed ID: 23792828
[TBL] [Abstract][Full Text] [Related]
17. [18F]FPhEP and [18F]F2PhEP, two new epibatidine-based radioligands: evaluation for imaging nicotinic acetylcholine receptors in baboon brain.
Valette H; Dollé F; Saba W; Roger G; Hinnen F; Coulon C; Ottaviani M; Syrota A; Bottlaender M
Synapse; 2007 Sep; 61(9):764-70. PubMed ID: 17568410
[TBL] [Abstract][Full Text] [Related]
18. Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition.
Easwaramoorthy B; Pichika R; Collins D; Potkin SG; Leslie FM; Mukherjee J
Synapse; 2007 Jan; 61(1):29-36. PubMed ID: 17068780
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
Chattopadhyay S; Xue B; Collins D; Pichika R; Bagnera R; Leslie FM; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
J Nucl Med; 2005 Jan; 46(1):130-40. PubMed ID: 15632043
[TBL] [Abstract][Full Text] [Related]
20. Radioligand imaging of α4β2* nicotinic acetylcholine receptors in Alzheimer's disease and Parkinson's disease.
Meyer PM; Tiepolt S; Barthel H; Hesse S; Sabri O
Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):376-86. PubMed ID: 25387119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
